Heidi E. Greulich
Broad Institute · 212 works · 37,879 citations · h-index 53
Top works
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- Somatic mutations affect key pathways in lung adenocarcinoma
- The landscape of somatic copy-number alteration across human cancers
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- High-throughput oncogene mutation profiling in human cancer
- Characterizing the cancer genome in lung adenocarcinoma
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
- BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
- Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
- Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
- Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions
- Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression